These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 37991331)

  • 1. Serum anti-Müllerian hormone: A potential biomarker for polycystic ovary syndrome.
    Halder A; Kumar H; Sharma M; Jain M; Kalsi AK; Pandey S
    Indian J Med Res; 2023 Oct; 158(4):397-406. PubMed ID: 37991331
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Polycystic ovarian morphology and the diagnosis of polycystic ovary syndrome: redefining threshold levels for follicle count and serum anti-Müllerian hormone using cluster analysis.
    Lie Fong S; Laven JSE; Duhamel A; Dewailly D
    Hum Reprod; 2017 Aug; 32(8):1723-1731. PubMed ID: 28854584
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The reference value of anti-Müllerian hormone to diagnose polycystic ovary syndrome is inversely associated with BMI: a retrospective study.
    Zhang M; Liu X; Xu X; Li J; Bu Z; Yang Q; Shi H; Niu W; Dai S; Liang Y; Guo Y
    Reprod Biol Endocrinol; 2023 Feb; 21(1):15. PubMed ID: 36726106
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Loss of anti-Müllerian hormone (AMH) immunoactivity due to a homozygous AMH gene variant rs10417628 in a woman with classical polycystic ovary syndrome (PCOS).
    Hoyos LR; Visser JA; McLuskey A; Chazenbalk GD; Grogan TR; Dumesic DA
    Hum Reprod; 2020 Oct; 35(10):2294-2302. PubMed ID: 32918081
    [TBL] [Abstract][Full Text] [Related]  

  • 5. DIAGNOSTIC VALUE OF ANTI-MÜLLERIAN HORMONE AS A BIOMARKER FOR POLYCYSTIC OVARY SYNDROME: A META-ANALYSIS UPDATE.
    Zhao Y; Zhao Y; Wang C; Liang Z; Liu X
    Endocr Pract; 2019 Oct; 25(10):1056-1066. PubMed ID: 31414908
    [No Abstract]   [Full Text] [Related]  

  • 6. AMH as part of the diagnostic PCOS workup in large epidemiological studies.
    Piltonen TT; Komsi E; Morin-Papunen LC; Korhonen E; Franks S; Järvelin MR; Arffman RK; Ollila MM
    Eur J Endocrinol; 2023 Jun; 188(6):547-554. PubMed ID: 37294941
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Elevated serum levels of anti-Müllerian hormone can be introduced as a new diagnostic marker for polycystic ovary syndrome.
    Sahmay S; Atakul N; Aydogan B; Aydin Y; Imamoglu M; Seyisoglu H
    Acta Obstet Gynecol Scand; 2013 Dec; 92(12):1369-74. PubMed ID: 23980726
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Accuracy of anti-Müllerian hormone and total follicles count to diagnose polycystic ovary syndrome in reproductive women.
    Wongwananuruk T; Panichyawat N; Indhavivadhana S; Rattanachaiyanont M; Angsuwathana S; Techatraisak K; Pratumvinit B; Sa-Nga-Areekul N
    Taiwan J Obstet Gynecol; 2018 Aug; 57(4):499-506. PubMed ID: 30122568
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Using cluster analysis to identify a homogeneous subpopulation of women with polycystic ovarian morphology in a population of non-hyperandrogenic women with regular menstrual cycles.
    Dewailly D; Alebić MŠ; Duhamel A; Stojanović N
    Hum Reprod; 2014 Nov; 29(11):2536-43. PubMed ID: 25267785
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Substituting serum anti-Müllerian hormone for polycystic ovary morphology increases the number of women diagnosed with polycystic ovary syndrome: a community-based cross-sectional study.
    Bell RJ; Islam RM; Skiba MA; Herbert D; Martinez Garcia A; Davis SR
    Hum Reprod; 2021 Dec; 37(1):109-118. PubMed ID: 34741176
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diagnostic value of anti-Müllerian hormone combined with androgen-levels in Chinese patients with polycystic ovary syndrome.
    Jiang L; Ruan X; Li Y; Gu M; Cheng J; Wang Y; Yang Y; Xu C; Wang Z; Liu L; Mueck AO
    Gynecol Endocrinol; 2023 Dec; 39(1):2206927. PubMed ID: 37141919
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Determining the age group-based cut-off values of serum anti-Mullerian hormone concentrations to diagnose polycystic ovary syndrome.
    Timur HT; Cimrin D; Gursoy Doruk O; Dogan OE
    Curr Med Res Opin; 2023 Jun; 39(6):855-863. PubMed ID: 37074782
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differentiation between polycystic ovary syndrome and polycystic ovarian morphology by means of an anti-Müllerian hormone cutoff value.
    Song DK; Oh JY; Lee H; Sung YA
    Korean J Intern Med; 2017 Jul; 32(4):690-698. PubMed ID: 27899014
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anti-Müllerian Hormone and Inhibin-A, but not Inhibin-B or Insulin-Like Peptide-3, may be Used as Surrogates in the Diagnosis of Polycystic Ovary Syndrome in Adolescents: Preliminary Results.
    Yetim A; Yetim Ç; Baş F; Erol OB; Çığ G; Uçar A; Darendeliler F
    J Clin Res Pediatr Endocrinol; 2016 Sep; 8(3):288-97. PubMed ID: 27125339
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Use of the serum anti-Müllerian hormone assay as a surrogate for polycystic ovarian morphology: impact on diagnosis and phenotypic classification of polycystic ovary syndrome.
    Fraissinet A; Robin G; Pigny P; Lefebvre T; Catteau-Jonard S; Dewailly D
    Hum Reprod; 2017 Aug; 32(8):1716-1722. PubMed ID: 28854589
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anti-Müllerian hormone reflects the severity of polycystic ovary syndrome.
    Jacob SL; Field HP; Calder N; Picton HM; Balen AH; Barth JH
    Clin Endocrinol (Oxf); 2017 Mar; 86(3):395-400. PubMed ID: 27805276
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antimüllerian hormone to determine polycystic ovarian morphology.
    Dietz de Loos A; Hund M; Buck K; Meun C; Sillman J; Laven JSE
    Fertil Steril; 2021 Oct; 116(4):1149-1157. PubMed ID: 34579824
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of Anti-müllerian Hormone (AMH) and Hormonal Assays for Phenotypic Classification of Polycystic Ovary Syndrome.
    Ozay AC; Emekcı Ozay O; Gulekli B
    Ginekol Pol; 2020; 91(11):661-667. PubMed ID: 33301159
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anti-Müllerian hormone as a diagnostic tool for PCOS under different diagnostic criteria in an unselected population.
    Bozdag G; Mumusoglu S; Coskun ZY; Yarali H; Yildiz BO
    Reprod Biomed Online; 2019 Sep; 39(3):522-529. PubMed ID: 31182353
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The role of anti-Mullerian hormone and other correlates in patients with polycystic ovary syndrome.
    Moursi MO; Salem H; Ibrahim AR; Marzouk S; Al-Meraghi S; Al-Ajmi M; Al-Naimi A; Alansari L
    Gynecol Endocrinol; 2023 Aug; 39(1):2247098. PubMed ID: 37573873
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.